Authors: MALYAK M GUTHRIDGE JM HANCE KR DOWER SK FREED JH AREND WP

Citation: M. Malyak et al., CHARACTERIZATION OF A LOW-MOLECULAR-WEIGHT ISOFORM OF IL-1 RECEPTOR ANTAGONIST, The Journal of immunology (1950), 161(4), 1998, pp. 1997-2003

Authors: MALYAK M SMITH MF ABEL AA HANCE KR AREND WP

Citation: M. Malyak et al., THE DIFFERENTIAL PRODUCTION OF 3 FORMS OF IL-1 RECEPTOR ANTAGONIST BYHUMAN NEUTROPHILS AND MONOCYTES, The Journal of immunology (1950), 161(4), 1998, pp. 2004-2010

Authors: MALYAK M SMITH MF HANCE KR DOWER SK AREND WP

Citation: M. Malyak et al., CHARACTERIZATION OF A NOVEL, 16 KD, INTRACELLULAR FORM OF IL-1 RECEPTOR ANTAGONIST (IL-1RA), Arthritis and rheumatism, 39(9), 1996, pp. 558-558

Authors: JANSON RW HANCE KR KING TE

Citation: Rw. Janson et al., HUMAN ALVEOLAR MACROPHAGES PRODUCE PREDOMINANTLY THE 35-KD PRO-FORMS OF INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA WHEN STIMULATED WITH LIPOPOLYSACCHARIDE, American journal of respiratory and critical care medicine, 151(5), 1995, pp. 1613-1620

Authors: JANSON RW KING TE HANCE KR AREND WP

Citation: Rw. Janson et al., ENHANCED PRODUCTION OF IL-1-RECEPTOR ANTAGONIST BY ALVEOLAR MACROPHAGES FROM PATIENTS WITH INTERSTITIAL LUNG-DISEASE, The American review of respiratory disease, 148(2), 1993, pp. 495-503